download preliminary programme


For past conferences, follow this link

Courtesy of Brisbane MarketingANZCNS 6th Annual Scientific Meeting
(Wednesday 9th - Friday 11th August 2017)
Brisbane Convention & Exhibition Centre, South Brisbane

Important Dates
27th March 2017  Abstract submission opens
Registration opens
26th June 2017  Abstract submission closes
Early bird registration closes
Accommodation bookings are subject to availability from this date
24th July 2017  All registration closes (no on-site registration)
9th-11th August  Conference

To Register
Register now at

Abstract Submission
Submit abstracts at
Abstract submission instructions can be found here »

Welcome message
The 6th Annual Scientific Meeting of the Australia and New Zealand Child Neurology Society will be held in South Brisbane at the Brisbane Convention & Exhibition Centre.

We warmly welcome you to this year’s annual scientific meeting.

Major Sponsors

UCB Australia

International Speaker Sponsors


The Program

download preliminary programme

We are delighted to announce our international speakers:

Marc C. PattersonMarc C. Patterson, MD, FRACP, FAAN, FANA, was born and educated in Australia, and trained in neurology, child neurology and neurometabolic disease at the University of Queensland, at Mayo Clinic, and at NINDS/NIH, the last mentioned under the guidance of Roscoe Brady, MD. He is currently Professor of Neurology, Pediatrics and Medical Genetics, and Chair of the Division of Child and Adolescent Neurology at Mayo Clinic, He was Director of the Child Neurology Training program at Mayo 2008-2016), and had previously served as Professor and Director of Pediatric Neurology at Columbia University in New York (2001-2007). He has served as a member of the Neurology topic advisory group for revision of the ICD-10 of the World Health Organization, the Committee on Adverse Effects of Vaccines for the Institute of Medicine, and leads the Education Core of the NIH-funded Lysosomal Disease Network.

He has served in a number of positions in the Child Neurology Society, American Academy of Neurology, American Board of Psychiatry and Neurology and American Neurological Association. Professor Patterson has served on the editorial board of Neurology, on the oversight committee of Annals of Neurology and is currently an Editor for the Journal of Inherited Metabolic Disease. He became Editor-in Chief of the Journal of Child Neurology on January 1st, 2014, and subsequently Editor-in-Chief of its open-access sister journal, Child Neurology Open.

His research and practice has focused on rare diseases in children, including multiple sclerosis and neurometabolic disorders in general, with special interests in Niemann-Pick disease, type C, other lysosomal diseases (including glycoproteinoses), mitochondrial cytopathies and congenital disorders of glycosylation, areas in which he has published more than 200 peer-reviewed papers and book chapters. He has presented widely through the United States and internationally, both to professional and lay organizations. Dr Patterson has received funding support from NIH, industry and private foundations.

Deborah L. RenaudDeborah L. Renaud is a graduate of the University of Western Ontario where she studied Biology and received her M.D. degree. She completed residency training in Pediatrics and Pediatric Neurology at the Children’s Hospital of Eastern Ontario in Ottawa and Hospital for Sick Children in Toronto. As a Clinical and Research Fellow in Genetic Metabolic Disorders at Hospital for Sick Children in Toronto, she completed a research fellowship in the Neurometabolics Laboratory

Dr. Renaud is a Fellow of the Royal College of Physicians and Surgeons of Canada in both Pediatrics and Neurology. She is a Diplomat of the American Board of Pediatrics and is certified in Neurology with Special Qualifications in Child Neurology by the American Board of Psychiatry and Neurology. More recently, she became certified in Medical Biochemical Genetics by the American Board of Medical Genetics and Genomics. She is an Associate Professor of Neurology and Pediatrics at the Mayo Medical School.

Dr. Renaud is a neurometabolic specialist at the Mayo Clinic in Rochester, MN focusing on neurologic manifestations of inherited metabolic disorders, with a particular interest in inherited leukoencephalopathies. She is the Director of the Neurometabolic Clinic and Leukodystrophy Program, which provide comprehensive evaluation and care for adults and children with neurometabolic disorders and inherited leukoencephalopahy.

Dr. Renaud is co-Director of the Mayo Clinic Peroxisomal Disorders Program, a multidisciplinary program for patients with peroxisomal disorders with special emphasis on boys with X-linked adrenoleukodystrophy (X-ALD) as well as men and women with adrenomyeloneuropathy (AMN). Specialized MRI protocols have been developed to detect leukodystrophy earlier in boys. In conjunction with colleagues, a reduced intensity stem cell transplantation program has been developed for boys with the leukodystrophy form. A multidisciplinary program with standardized protocols has been developed for men and women with AMN in conjunction with Endocrinology, Urology and the Spine Center.

Charlotte J. Sumner Charlotte J. Sumner is a Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. She received her B.A. from Princeton University and her M.D. from the University of Pennsylvania School of Medicine. She completed internal medicine internship and neurology residency at the University of California San Francisco and neuromuscular fellowship at Johns Hopkins University School of Medicine. Her scientific training included Neurogenetics fellowship at the National Institute of Neurological Disorders and Stroke. She cares for patients with inherited diseases of motor neurons and peripheral nerve and co-directs the Johns Hopkins Spinal Muscular Atrophy and Charcot Marie Tooth disease clinics. Dr. Sumner’s research focuses on the genetic and cellular pathogenesis of SMAs with particular attention to identification of novel disease genes, characterization of molecular and cellular mechanisms underlying disease pathogenesis, and preclinical development of novel therapeutics. Her work has been supported by the National Institute of Neurological Diseases and Stroke, Howard Hughes Medical Institute, and disease foundations. She is an Associate Editor of the journal Experimental Neurology and is the co-editor of the only comprehensive book on SMA: Spinal Muscular Atrophy Disease Mechanisms and Therapy. She has also been advisor to several companies developing treatments for SMA and nonprofit disease foundations including the Packard Center for ALS research, Muscular Dystrophy Association, Cure SMA, and the SMA Foundation.

International epilepsy speaker – announcement coming soon! This speaker and their contributions will be announced once confirmed.

National/regional speakers:

Nicholas Smith, WCHA Adelaide. Nicholas Smith is a neurologist specialising in the management of paediatric and adult neurometabolic diseases, with a particular interest in the disorders of lysosomal function. His clinical and scientific research interests focus upon defining the pathological mechanisms underpinning neurological forms of lysosomal disease to inform the development of novel therapeutic approaches, including gene transfer therapies, for children and adults with lysosomal and related neurodegenerative disorders. We are very pleased to have Nick contribute with our international speakers to the Neurometabolic Symposium, speaking on gene therapies in neurodegenerative diseases.

Linda Richards, Queensland Brain Institute, University of Queensland. Linda Richards, is Professor of Neuroscience and Deputy Director of the Queensland Brain Institute at The University of Queensland, Brisbane, Australia. She is a Fellow of both the Australian Academy of Science and the Australian Academy of Health and Medical Sciences and is a National Health and Medical Research Council Principal Research Fellow. She is President of the Australasian Neuroscience Society and a member of the steering committee and spokesperson of the Australian Brain Alliance. Professor Richards is head of the brain development and developmental disorders laboratory at QBI. Her laboratory team strives to understand how the brain forms during development and how these processes are disrupted causing human developmental brain disorders and brain cancer. Prof Richards co-founded an International Consortium for the Corpus Callosum and Cerebral Connectivity with colleagues from Melbourne, San Francisco, France and Brazil. The consortium brings together clinicians and scientists working to identify the causes of developmental brain disorders and how best to provide support and care for affected individuals and their families. Well known for her work in this area, Prof Richards will present on development and malformations of the corpus callosum.

David Reutens, Centre for Advanced Imaging, University of Queensland. Prof Reutens is the Director of the Centre for Advanced Imaging and previous Professor of Neuroscience at Monash University. He is also a clinical neurologist specialising in epilepsy and is a senior staff specialist at the Royal Brisbane and Women’s Hospital. He directs the Australian Mouse Brain Mapping Consortium. Research in the Reuten’s Lab focuses the development of imaging methods, the study/prediction of epileptogenesis, antiepileptogenic therapies and the study of anti epileptic diets using animal models of epilepsy, such as zebrafish and mice. Prof Reutens will present on the theme of disease-modifying strategies for the process of epileptogenesis.

Alex Lehn, Adult Neurologist, Functional Neurological Disorders Clinic, Mater Hospital, Queensland. Dr Alexander Lehn attended medical school in Germany and conducted his residency and basic physician training in the United Kingdom and Australia. He then undertook a Fellowship in movement disorders. He runs the deep brain stimulation service at Mater Hospital Brisbane. He leads a novel functional neurological disorders clinic in Brisbane, and has an active research interest in these complex presentations, their diagnosis and management. He will present on current research and concepts regarding functional disorders, some of which were highlighted on a 2016 SBS Insight documentary, Mind Versus Body

Sophie Calvert, Paediatric Neurologist, Lady Client Children’s Hospital. Dr Sophie Calvert is a paediatric neurologist based in Brisbane. Sophie began paediatric training at the Women’s and Children’s Hospital in Adelaide, moving on to do Advanced Training in Paediatric Neurology in the UK, working in Bristol and at Great Ormond Street Hospital, London. Dr Calvert worked as a consultant at Evelina Chidren’s Hospital, King College Hospital in London and the John Radcliffe Hospital in Oxford before moving to take on her current post in Brisbane. She established the Queensland Statewide Paediatric Ketogenic Diet Service and started the Paediatric Headache clinic at Lady Cilento Children’s Hospital. Dr Calvert will talk on unusual headaches in children, clinical headache trials.

Other program highlights (further updates expected): Conference Dinner
This will be held on the evening of 10th August, at the Summit Restaurant (with spectacular near 360 degree views of Brisbane and surrounds), Mt Coot-tha, Brisbane.

The Conference Venue
Brisbane Convention & Exhibition Centre, South Brisbane.

The Conference Hotel
Rydges South Bank Brisbane, 9 Glenelg Street, Brisbane QLD 4000


Located in the heart of Brisbane’s arts and entertainment precinct, Rydges South Bank Brisbane accommodation has a wide range of attractions on its doorstep including the South Bank Parklands and the Brisbane Convention & Exhibition Centre.

The rate is $259 per room per night.
Complimentary wi-fi is included for all group guests staying in house.
Rates are applicable for up to 2 adults; extra adults charged at $60 per night.
Daily full buffet breakfast is available for $39pp. May be purchased directly with the hotel during your stay.

Cancellations or reduction of room nights received after 30 days prior to the 9th August will incur a charge to equal 1 nights accommodation per booking cancelled.
Cancellations or amendments to existing bookings after 14days prior to the 9th August will incur a charge equivalent to the full duration of the stay.
No shows will be charged for the duration of the booking.

Registration Fees

Fee Type Early Fee (Payment by 26th June 2017) Standard Fee
Full Registration
ANZCNS Ordinary Member (Consultant Physician) $650 $850
ANZCNS Trainee Member (Medical, Postgraduate) $300 $450
ANZCNS Retired Member (Physician) $300 $300
ANZCNS Associate Member (Allied Health, Nursing, Neurophysiology) $300 $450
Non Member Consultant Physician $800 $1000
Non Member Trainee (Medical, Postgraduate) $450 $600
Non Member Retired Physician $300 $300
Non Member Special Groups (Allied Health, Nursing, Neurophysiology) $450 $600
Medical Student (Undergraduate) $200 $200
All other professions $800 $1000
Day Registrations
No concession $350 $350
Concession (Allied Health, Nursing, Neurophysiology) $200 $200

Registration Entitlements

Alterations and Cancellations
Alterations or cancellations to your registration and/or accommodation bookings will not be accepted over the telephone. Alterations must be requested via email.

Notice of cancellation for registration/accommodation bookings, when received in writing, will be processed and your registration/accommodation fee refunded subject to the following deductions:

Australia and New Zealand Child Neurology Society, ABN 12 146 982 452, ACN 146 982 452